Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma

Meng Sha; Chuan Shen; Seogsong Jeong; Ning Xu; Chen Chen; Hua-lian Hang; Ying Tong; Jie Cao

doi:10.1016/j.gendis.2023.02.023

您当前的位置：

首页 >

文章列表页 >

Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma

Rapid Communications | 更新时间：2024-02-04

- Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma
- Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma
- Genes & Diseases 2023年1卷第6期页码：2226-2228
- 作者机构：
  
  1. Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University,Shanghai,China,200127
  2. Department of Biomedical Informatics, CHA University School of Medicine, CHA University, Seongnam 13488, Republic of Korea
  3. Institute of Basic Medical Sciences, School of Medicine, CHA University, Seongnam 13488, Republic of Korea
  4. Institute for Biomedical Informatics, School of Medicine, CHA University, Seongnam 13488, Republic of Korea
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.02.023
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-11-1，
扫描看全文
Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma[J]. Genes & Diseases, 2023,1(6):2226-2228.

Meng Sha, Chuan Shen, Seogsong Jeong, et al. Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma[J]. Genes & Diseases, 2023,1(6):2226-2228.
Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma[J]. Genes & Diseases, 2023,1(6):2226-2228. DOI： 10.1016/j.gendis.2023.02.023.

Meng Sha, Chuan Shen, Seogsong Jeong, et al. Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma[J]. Genes & Diseases, 2023,1(6):2226-2228. DOI： 10.1016/j.gendis.2023.02.023.

摘要

Abstract

关键词

Keywords

references

1 M. Sha, S. Jeong, X. Wang, et al.Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma BMC Cancer, 19 (1) (2019), p. 208

2 G. Valenti, H.M. Quinn, G.J.J.E. Heynen, et al.Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors Cancer Res, 77 (8) (2017), pp. 2134-2147

3 L. Li, W. LiEpithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation Pharmacol Ther, 150 (2015), pp. 33-46

4 Y. Kubouchi, Y. Yurugi, M. Wakahara, et al.Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma Histopathology, 72 (3) (2018), pp. 490-499

5 S. Neri, G. Ishii, H. Hashimoto, et al.Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma Int J Cancer, 137 (4) (2015), pp. 784-796

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据